These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39260365)

  • 1. An improved approach to generate IL-15
    Chen AP; Gao P; Lin L; Ashok P; He H; Ma C; Zou DL; Allain V; Boyne A; Juillerat A; Duchateau P; Rath A; Teper D; Arulanandam A; Chang HM; Eyquem J; Li W
    Cell Rep Methods; 2024 Sep; 4(9):100857. PubMed ID: 39260365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells.
    Thangaraj JL; Coffey M; Lopez E; Kaufman DS
    Cell Stem Cell; 2024 Sep; 31(9):1327-1343.e5. PubMed ID: 38986609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of individualized immunocompatible endothelial cells from HLA-I-matched human pluripotent stem cells.
    Song C; Wang L; Li Q; Liao B; Qiao W; Li Q; Dong N; Li L
    Stem Cell Res Ther; 2022 Feb; 13(1):48. PubMed ID: 35109922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Natural Killer Cells Differentiated from Various Pluripotent Stem Cells.
    Han J; Son H; Jung D; Kim KY; Jin C; Hwang H; Kang SS; Mitalipov S; An HJ; Lee Y; Kang E
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scalable, spin-free approach to generate enhanced induced pluripotent stem cell-derived natural killer cells for cancer immunotherapy.
    Rossi GR; Sun J; Lin CY; Wong JK; Alim L; Lam PY; Khosrotehrani K; Wolvetang E; Cheetham SW; Derrick EB; Amoako A; Lehner C; Brooks AJ; Beavis PA; Souza-Fonseca-Guimaraes F
    Immunol Cell Biol; 2024 Nov; 102(10):924-934. PubMed ID: 39269338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors.
    Bogomiakova ME; Sekretova EK; Anufrieva KS; Khabarova PO; Kazakova AN; Bobrovsky PA; Grigoryeva TV; Eremeev AV; Lebedeva OS; Bogomazova AN; Lagarkova MA
    Stem Cell Res Ther; 2023 Apr; 14(1):77. PubMed ID: 37038186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting.
    Snyder KM; Dixon KJ; Davis Z; Hosking M; Hart G; Khaw M; Matson A; Bjordahl R; Hancock B; Shirinbak S; Miller JS; Valamehr B; Wu J; Walcheck B
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity.
    Li Y; Hermanson DL; Moriarity BS; Kaufman DS
    Cell Stem Cell; 2018 Aug; 23(2):181-192.e5. PubMed ID: 30082067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and transcriptomic profiling of induced pluripotent stem cell (iPSC)-derived NK cells and their cytotoxicity against cancers.
    Thongsin N; Suwanpitak S; Augsornworawat P; Srisantitham J; Saiprayong K; Jenjaroenpun P; Wattanapanitch M
    Stem Cell Res Ther; 2024 Nov; 15(1):418. PubMed ID: 39533434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of universal natural killer cells from a cryopreserved cord blood mononuclear cell-derived induced pluripotent stem cell library.
    Du W; Cui L; Zhang J; Zhang H; Liu R; Yang W; Zhang Y
    FEBS Open Bio; 2022 Oct; 12(10):1771-1781. PubMed ID: 35747945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of "Off-the-Shelf" Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells.
    Zeng J; Tang SY; Toh LL; Wang S
    Stem Cell Reports; 2017 Dec; 9(6):1796-1812. PubMed ID: 29173894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy.
    Woan KV; Kim H; Bjordahl R; Davis ZB; Gaidarova S; Goulding J; Hancock B; Mahmood S; Abujarour R; Wang H; Tuininga K; Zhang B; Wu CY; Kodal B; Khaw M; Bendzick L; Rogers P; Ge MQ; Bonello G; Meza M; Felices M; Huffman J; Dailey T; Lee TT; Walcheck B; Malmberg KJ; Blazar BR; Bryceson YT; Valamehr B; Miller JS; Cichocki F
    Cell Stem Cell; 2021 Dec; 28(12):2062-2075.e5. PubMed ID: 34525347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of iPSC-derived NK cells from two differentiation strategies reveals distinct signatures and cytotoxic activities.
    Huyghe M; Desterke C; Imeri J; Belliard N; Chaker D; Oudrirhi N; Bezerra H; Turhan AG; Bennaceur-Griscelli A; Griscelli F
    Front Immunol; 2024; 15():1463736. PubMed ID: 39445004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifunctional TGF-β trap/IL-15 protein complex elicits potent NK cell and CD8
    Liu B; Zhu X; Kong L; Wang M; Spanoudis C; Chaturvedi P; George V; Jiao JA; You L; Egan JO; Echeverri C; Gallo VL; Xing J; Ravelo K; Prendes C; Antolinez J; Denissova J; Muniz GJ; Jeng EK; Rhode PR; Wong HC
    Mol Ther; 2021 Oct; 29(10):2949-2962. PubMed ID: 34091051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma.
    Dixon KJ; Snyder KM; Khaw M; Hullsiek R; Davis ZB; Matson AW; Shirinbak S; Hancock B; Bjordahl R; Hosking M; Miller JS; Valamehr B; Wu J; Walcheck B
    Front Immunol; 2024; 15():1407567. PubMed ID: 39100677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iPSC-Derived Natural Killer Cells for Cancer Immunotherapy.
    Karagiannis P; Kim SI
    Mol Cells; 2021 Aug; 44(8):541-548. PubMed ID: 34373366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic correction of induced pluripotent stem cells mediated by transcription activator-like effector nucleases targeting ALPL recovers enzyme activity and calcification in vitro.
    Nakano C; Kitabatake Y; Takeyari S; Ohata Y; Kubota T; Taketani K; Kogo M; Ozono K
    Mol Genet Metab; 2019 Jun; 127(2):158-165. PubMed ID: 31178256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells.
    Tang SY; Zha S; Du Z; Zeng J; Zhu D; Luo Y; Wang S
    Stem Cell Res Ther; 2021 Nov; 12(1):580. PubMed ID: 34802459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity.
    Flahou C; Morishima T; Takizawa H; Sugimoto N
    Front Immunol; 2021; 12():662360. PubMed ID: 33897711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of D1-1 TALEN isogenic control cell line from Dravet syndrome patient iPSCs using TALEN-mediated editing of the SCN1A gene.
    Tanaka Y; Sone T; Higurashi N; Sakuma T; Suzuki S; Ishikawa M; Yamamoto T; Mitsui J; Tsuji H; Okano H; Hirose S
    Stem Cell Res; 2018 Apr; 28():100-104. PubMed ID: 29453127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.